Penn State researchers discovered that two proteins within the CCR4-NOT complex have opposing effects on mRNA stability.

Research shows how cells respond to brain injury by releasing corticotropin-releasing hormone, which helps to repair damage.

Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced that the U.S. Food and Drug Administration (FDA) has cleared its ...

This study reports a valuable method to predict the capacity of a candidate probiotic bacterium to metabolically outcompete a bacterial pathogen in the ecological niche of the murine respiratory tract ...